(Q45344545)

13 December 2017

title

P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging (English)

1 reference

Anabela Cordeiro-da-Silva

13 December 2017

author

6

1 reference

13 December 2017

8

1 reference

13 December 2017

Vânia Vilas-Boas

1

0 references

Sofia A Costa Lima

object named as

Sofia Costa Lima

5

0 references

Renata Silva

object named as

Renata Silva

2

0 references

Maria de Lourdes Bastos

object named as

Maria de Lourdes Bastos

7

0 references

author name string

A Rita Gaio

3

1 reference

13 December 2017

Ana Margarida Martins

4

1 reference

13 December 2017

publication date

8 September 2011

1 reference

13 December 2017

1 reference

13 December 2017

volume

79

1 reference

13 December 2017

issue

11

1 reference

13 December 2017

page(s)

912-919

1 reference

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

How can we best use structural information on P-glycoprotein to design inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

The aging immune system: primer and prospectus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

P-glycoprotein function in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Analysis of P-glycoprotein-mediated membrane transport in human peripheral blood lymphocytes using the UIC2 shift assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Detection of P-glycoprotein in cell lines and leukemic blasts: failure of select monoclonal antibodies to detect clinically significant Pgp levels in primary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

The detection of rhodamine 123 efflux at low levels of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

P-glycoprotein functions in peripheral-blood CD4+ cells of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine A analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

7 January 2021

The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

7 January 2021

Detection of the MDR1 P-glycoprotein expression and function

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

7 January 2021

Discordance of P-glycoprotein expression and function in acute leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.21135

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.21135

1 reference

13 December 2017

1 reference